MAZE
Maze Therapeutics, Inc.
36.73
+1.28 (+3.61%)
52w low 21.95
53.65 high
46.6% of range
MAZE · 6M
—
O--
H--
L--
C--
Chg--
Gap--
Vol--
×avg--
σ--
SMA20--
SMA50--
SMA200--
RSI--
SPY--
DD--
Bench--
Sig--
Hist--
pinned · Esc to release
hover · click to pin · ← → step · drag to zoom · shift-drag to measure
SMA 20SMA 50
—Context
- Move across the chart.
Events in view
| Date | Kind | Event | Source |
|---|---|---|---|
| 2026-11-09 | filing | 8-K: results of operations (earnings) | SEC EDGAR |
| 2026-11-09 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-10-16 | filing | 8-K: material agreement; unregistered sale of equity (dilution) | SEC EDGAR |
| 2026-08-17 | filing | 8-K: officer / director change; Reg FD disclosure | SEC EDGAR |
| 2026-08-11 | filing | 8-K: results of operations (earnings) | SEC EDGAR |
| 2026-08-11 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-06-10 | filing | 8-K: shareholder vote | SEC EDGAR |
| 2026-05-22 | filing | 8-K: officer / director change | SEC EDGAR |
| 2026-05-12 | filing | 8-K: results of operations (earnings) | SEC EDGAR |
| 2026-05-12 | filing | 10-Q (quarterly report) | SEC EDGAR |
Performance
1D
+3.61%
5D
+10.04%
1M
+32.60%
3M
+33.42%
6M
+36.24%
YTD
-11.34%
1Y
+13.86%
2Y
--
3Y
--
5Y
--
MAX
+130.28%
Period
+38.76%
High
37.41
Low
21.95
Ann Vol
43.61%
Sharpe
0.88
Max DD
-31.82%
ATR (14)
1.72